Table 1: Patient demographic and clinical characteristics at baseline (total and differences according insulin treatment). Values are expressed as mean ± standard deviation (SD). DPP-4 Inhibitors: dipeptidyl peptidase-4 inhibitors; SGLT2 Inhibitors: sodium glucose cotransporter 2 inhibitors. eGFR: estimated glomerular filtrate rate. ACEIs/ARBs: Angiotensin-converting-enzyme inhibitors/Angiotensin II receptor blockers.

Table 2